CRISPR THERAPEUTICS Trademark

Trademark Overview

On Tuesday, September 5, 2023, a trademark application was filed for CRISPR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CRISPR THERAPEUTICS trademark a serial number of 98164705. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, May 1, 2024. This trademark is owned by CRISPR Therapeutics AG. The CRISPR THERAPEUTICS trademark is filed in the Pharmaceutical Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Education services, namely, providing online non-downloadable articles and newsletters in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders

Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to i...
crispr therapeutics

General Information

Serial Number98164705
Word MarkCRISPR THERAPEUTICS
Filing DateTuesday, September 5, 2023
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateWednesday, May 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesEducation services, namely, providing online non-downloadable articles and newsletters in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
Description of MarkThe mark consists of an incomplete square with a break in the lower right of the square. At the bottom of the square below the break appears a shaded rectangle. In the lower middle of the square appears the stylized word "CRISPR", with the second "R" connected to the square. In the shaded rectangle appears the stylized word "THERAPEUTICS".
Goods and ServicesCells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 28, 2023
Primary Code005
First Use Anywhere DateMonday, July 22, 2019
First Use In Commerce DateMonday, July 22, 2019
International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, September 28, 2023
Primary Code041
First Use Anywhere DateThursday, October 31, 2013
First Use In Commerce DateThursday, October 31, 2013
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 28, 2023
Primary Code042
First Use Anywhere DateThursday, October 31, 2013
First Use In Commerce DateThursday, October 31, 2013

Trademark Owner History

Party NameCRISPR Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZUG V8 6300
CH

Trademark Events

Event DateEvent Description
Friday, September 8, 2023NEW APPLICATION ENTERED
Thursday, September 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 29, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 1, 2024ASSIGNED TO EXAMINER

Related Keywords

therapeutics crispr gene editing modulation research pharmaceuticals scientific therapy genome transcriptional genetic